240 related articles for article (PubMed ID: 32712273)
1. Xie2-64, a novel CB
Jordan CJ; Feng ZW; Galaj E; Bi GH; Xue Y; Liang Y; McGuire T; Xie XQ; Xi ZX
Neuropharmacology; 2020 Oct; 176():108241. PubMed ID: 32712273
[TBL] [Abstract][Full Text] [Related]
2. Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT
Galaj E; Bi GH; Yang HJ; Xi ZX
Neuropharmacology; 2020 May; 167():107740. PubMed ID: 31437433
[TBL] [Abstract][Full Text] [Related]
3. Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice.
Tai S; Vasiljevik T; Sherwood AM; Eddington S; Wilson CD; Prisinzano TE; Fantegrossi WE
Drug Alcohol Depend; 2018 Nov; 192():285-293. PubMed ID: 30300803
[TBL] [Abstract][Full Text] [Related]
4. Brain cannabinoid CB₂ receptors modulate cocaine's actions in mice.
Xi ZX; Peng XQ; Li X; Song R; Zhang HY; Liu QR; Yang HJ; Bi GH; Li J; Gardner EL
Nat Neurosci; 2011 Jul; 14(9):1160-6. PubMed ID: 21785434
[TBL] [Abstract][Full Text] [Related]
5. Species differences in cannabinoid receptor 2 and receptor responses to cocaine self-administration in mice and rats.
Zhang HY; Bi GH; Li X; Li J; Qu H; Zhang SJ; Li CY; Onaivi ES; Gardner EL; Xi ZX; Liu QR
Neuropsychopharmacology; 2015 Mar; 40(4):1037-51. PubMed ID: 25374096
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol inhibits sucrose self-administration by CB1 and CB2 receptor mechanisms in rodents.
Bi GH; Galaj E; He Y; Xi ZX
Addict Biol; 2020 Jul; 25(4):e12783. PubMed ID: 31215752
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice.
Zhang HY; Gao M; Liu QR; Bi GH; Li X; Yang HJ; Gardner EL; Wu J; Xi ZX
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):E5007-15. PubMed ID: 25368177
[TBL] [Abstract][Full Text] [Related]
8. (±)VK4-40, a novel dopamine D
Jordan CJ; He Y; Bi GH; You ZB; Cao J; Xi ZX; Newman AH
Br J Pharmacol; 2020 Oct; 177(20):4796-4807. PubMed ID: 32851643
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research.
Galaj E; Hempel B; Moore A; Klein B; Bi GH; Gardner EL; Seltzman HH; Xi ZX
Transl Psychiatry; 2022 Jul; 12(1):286. PubMed ID: 35851573
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid CB
He XH; Jordan CJ; Vemuri K; Bi GH; Zhan J; Gardner EL; Makriyannis A; Wang YL; Xi ZX
Acta Pharmacol Sin; 2019 Mar; 40(3):365-373. PubMed ID: 29967454
[TBL] [Abstract][Full Text] [Related]
11. Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders.
Galaj E; Xi ZX
CNS Drugs; 2019 Oct; 33(10):1001-1030. PubMed ID: 31549358
[TBL] [Abstract][Full Text] [Related]
12. Opposing roles of CB
Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of aminoalkylindole derivatives as cannabinoid receptor ligands with potential for treatment of alcohol abuse.
Vasiljevik T; Franks LN; Ford BM; Douglas JT; Prather PL; Fantegrossi WE; Prisinzano TE
J Med Chem; 2013 Jun; 56(11):4537-50. PubMed ID: 23631463
[TBL] [Abstract][Full Text] [Related]
14. YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice.
Song R; Yang RF; Wu N; Su RB; Li J; Peng XQ; Li X; Gaál J; Xi ZX; Gardner EL
Addict Biol; 2012 Mar; 17(2):259-73. PubMed ID: 21507153
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.
Amenta PS; Jallo JI; Tuma RF; Hooper DC; Elliott MB
J Neuroinflammation; 2014 Nov; 11():191. PubMed ID: 25416141
[TBL] [Abstract][Full Text] [Related]
16. Metabotropic glutamate receptor 7 modulates the rewarding effects of cocaine in rats: involvement of a ventral pallidal GABAergic mechanism.
Li X; Li J; Peng XQ; Spiller K; Gardner EL; Xi ZX
Neuropsychopharmacology; 2009 Jun; 34(7):1783-96. PubMed ID: 19158667
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.
Xi ZX; Spiller K; Pak AC; Gilbert J; Dillon C; Li X; Peng XQ; Gardner EL
Neuropsychopharmacology; 2008 Jun; 33(7):1735-45. PubMed ID: 17728698
[TBL] [Abstract][Full Text] [Related]
18. Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behaviour.
Grey J; Terry P; Higgs S
Behav Pharmacol; 2012 Sep; 23(5-6):551-9. PubMed ID: 22772336
[TBL] [Abstract][Full Text] [Related]
19. Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB₂ receptors.
Aracil-Fernández A; Trigo JM; García-Gutiérrez MS; Ortega-Álvaro A; Ternianov A; Navarro D; Robledo P; Berbel P; Maldonado R; Manzanares J
Neuropsychopharmacology; 2012 Jun; 37(7):1749-63. PubMed ID: 22414816
[TBL] [Abstract][Full Text] [Related]
20. Expression of functional cannabinoid CB
Zhang HY; Gao M; Shen H; Bi GH; Yang HJ; Liu QR; Wu J; Gardner EL; Bonci A; Xi ZX
Addict Biol; 2017 May; 22(3):752-765. PubMed ID: 26833913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
